---
title: "Definium Therapeutics Appoints Roger Adsett to Board of Directors"
description: "Definium Therapeutics Inc. has appointed Roger Adsett to its Board of Directors. Adsett has over 20 years of experience in the biopharmaceutical industry, focusing on drug launches and building global"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/274145221.md"
published_at: "2026-01-29T12:00:52.000Z"
---

# Definium Therapeutics Appoints Roger Adsett to Board of Directors

> Definium Therapeutics Inc. has appointed Roger Adsett to its Board of Directors. Adsett has over 20 years of experience in the biopharmaceutical industry, focusing on drug launches and building global commercial organizations.

Definium Therapeutics Inc. has appointed Roger Adsett to its Board of Directors. Adsett brings over two decades of experience in the biopharmaceutical industry, specializing in drug launches and building global commercial organizations. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Definium Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260129459559) on January 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [DFTX.US - Definium Therapeutics](https://longbridge.com/en/quote/DFTX.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Definium Therapeutics Grants Stock Options to New Employees | Definium Therapeutics Inc. has granted stock options to three new non-executive employees, totaling 88,850 common shares | [Link](https://longbridge.com/en/news/273745776.md) |
| Definium Therapeutics Adds Commercial Leader As Phase 3 Milestones Approach | Definium Therapeutics has appointed Roger Adsett, a seasoned biopharmaceutical executive, to its Board of Directors as i | [Link](https://longbridge.com/en/news/274377675.md) |
| VA reverses on new disability rating rule after intense backlash | The Department of Veterans Affairs (VA) has reversed a controversial rule that calculated veterans' disability ratings b | [Link](https://longbridge.com/en/news/276476721.md) |
| 23:20 ETArisGlobal bringt XDI auf den Markt | ArisGlobal, a leading AI-driven technology company in life sciences, has launched XDI, its Data Intelligence Cortex. XDI | [Link](https://longbridge.com/en/news/276830770.md) |
| Definium defines LSD’s psychiatric applications in new campaign | Definium Therapeutics, formerly MindMed, is launching an educational campaign titled "Rerouting Minds" to promote the ps | [Link](https://longbridge.com/en/news/273117634.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.